Back to search
CPSCCPSC · Consumer products·Recall number 21729

Evrysdi™ (risdiplam)

Published March 18, 2021

Summary

CPSC records recall 21729, published March 18, 2021. Recalling firm: Genentech, a member of the Roche Group, of South San Francisco, Calif.; Reported units: About 14,000.

What's the hazard

The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).

What to do

Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.

Get an email if Genentech, a member of the Roche Group has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
Genentech, a member of the Roche Group, of South San Francisco, Calif.
Manufacturer
Genentech, a member of the Roche Group, of South San Francisco, Calif.
Distributor
Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
Country
US

Related recalls

Questions about this recall

Was Evrysdi™ (risdiplam) recalled?

Yes. CPSC published recall 21729 on March 18, 2021. Reported hazard: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).

What should I do if I have this product?

Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: Genentech, a member of the Roche Group, of South San Francisco, Calif..

View official CPSC notice(opens on cpsc.gov)